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Abstract.  Microtubule-associated proteins (MAPs)  in 
neurons establish functional associations with microtu- 
bules,  sometimes at considerable distances from their 
site of synthesis. In this study we identified MAP  1A 
in mouse retinal ganglion cells and characterized for 
the first time its in vivo dynamics in relation to ax- 
onally transported tubulin.  A  soluble 340-kD polypep- 
tide was strongly radiolabeled in ganglion cells after 
intravitreal injection of [35S]methionine or [3H]proline. 
This polypeptide was identified as MAP  1A on the ba- 
sis of its co-migration on SDS gels with MAP  1A 
from brain microtubules; its co-assembly with micro- 
tubules in the presence of taxol or during cycles of as- 
sembly-disassembly; and its cross-reaction with well- 
characterized antibodies against MAP  1A in immuno- 
blotting and immunoprecipitation assays. Glial cells of 
the optic nerve synthesized considerably less MAP 
1A than neurons. The axoplasmic transport of MAP 
1A differed from that of tubulin.  Using two separate 
methods, we observed that MAP  1A advanced along 
optic axons at a  rate of 1.0-1.2  mm/d, a  rate typical of 
the Group IV (SCb)  phase of transport,  while tubulin 
moved 0.1-0.2  nun/d, a  group V  (SCa) transport rate. 
At least 13%  of the newly synthesized MAP  1A enter- 
ing optic axons was incorporated uniformly along 
axons into stationary axonal structures.  The half- 
residence time of stationary MAP  1A in axons (55- 
60 d) was 4.6 times longer than that of MAP  1A mov- 
ing in Group IV,  indicating that at least 44%  of the 
total MAP  1A in axons is stationary. These results 
demonstrate that cytoskeletal proteins that become 
functionally associated with each other in axons may 
be delivered to these sites at different transport rates. 
Stable associations between axonal constituents moving 
at different velocities could develop when these ele- 
ments leave the transport vector and incorporate into 
the stationary cytoskeleton. 
M 
ICROTUBULES are composed of tubulin and a di- 
verse  group  of  microtubule-associated  proteins 
(MAPs) t that are defined by their persistent as- 
sociation with microtubules after repeated cycles of tubulin 
assembly  and  disassembly  in  vitro  (Murphy and  Borisy, 
1975; Sloboda et al.,  1976).  In the nervous system, certain 
MAPs seem to impart distinctive functional characteristics 
to the microtubule populations in different neuronal com- 
partments  (Hirokawa et  al.,  1988).  MAP  2  comprises  a 
group of  three closely related phosphoproteins, MAP 2A and 
MAP 2B (both at "~280 kD), and a 70-kD polypeptide, MAP 
2C, which are abundant in dendrites and rare in axons (Ma- 
tus et al.,  1981; Vallee,  1980;  Caceres  et  al.,  1984;  De- 
Camilli et al., 1984). Tau proteins (45-60 kD), another faro- 
1. Abbreviation  used in this paper:  MAP, microtubule-associated protein. 
ily of phosphoproteins, are enriched in axons (Weingarten et 
al.,  1975; Cleveland et al.,  1977; Lindwall et al.,  1984; 
Binder et al.,  1985).  MAP 1 polypeptides (~340 kD) are 
less  well-characterized.  Although  nomenclatures  for  in- 
dividual MAP  1 forms differ among laboratories, at least 
three polypeptides are distinguished on the basis of struc- 
tural, developmental and immunocytochemical studies (Bloom 
et al.,  1984;  Schoenfeld et al.,  1989;  for review,  Vallee, 
1984; Olmsted, 1986; Matus, 1988).  MAP 1A, or MAP 1, 
distributes throughout axons and dendritic processes and is 
expressed  at  increasing  levels  as development progresses 
(Bloom et al., 1984; Herrmann et al., 1985; Huber and Ma- 
tus, 1984; Herrmann et al.,  1985; Luca et al., 1986).  MAP 
1B and its putative cellular isotypes, MAP 5 (Riederer et al., 
1986),  MAP  1X (Calvert and Anderton,  1985),  and MAP 
1.2 (Asai  et al.,  1985),  are abundant early in development 
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Calvert and Anderton,  1985;  Riederer et al.,  1986;  Safaei 
and Fischer,  1989).  MAP IA and MAP IB appear to have 
little structural similarity (Bloom et al., 1985; Herrmann et 
al., 1985); however, both proteins associate with similar low 
molecular  weight polypeptides  (Vallee  and  Davis,  1983; 
Schoenfeld et al.,  1989).  MAP 1C, a dynein-like microtu- 
bole-activated ATPase (Paschal and Vallee,  1987),  is struc- 
turally distinct from other high molecular weight MAPS. 
Various  roles have been ascribed to MAPs in regulating 
the assembly, stability, and spatial organization of microtu- 
boles. Tau promotes the assembly of microtubules (Weingar- 
ten et al., 1975) and, like MAP 2, stabilizes these structures 
partly by inhibiting their disassembly (Black and Greene, 
1982; Drubin and Kirschner,  1986; Kosik et al., 1988; Schliwa 
et al., 1981). MAPs may also regulate interactions of micro- 
tubules with each other and with other cytoskeletal proteins 
(Olmsted, 1986). MAP 2 projects radially from the microtu- 
bule surface (Vallee,  1980) and, in dendrites, forms a cross- 
bridge between microtubules and neurofilaments (Leterrier 
et al., 1982; Heimann et al., 1985; Hirokawa et al., 1988). 
MAP 1A may compose cross-bridges between microtubules 
(Hirokawa,  1982;  Shiomura and Hirokawa,  1987a,b).  The 
appearance of MAP 1A in neurons relatively late in postnatal 
development coincides with changes in the organization of 
the  cytoskeleton that  may  stabilize  a  particular  neuronal 
shape or intracellular latticework. Although electron micro- 
scope images and in vitro assembly assays seem to confirm 
the physical association between MAPs and microtubules, 
relatively little is known about the dynamics of these interac- 
tions in vivo. 
One potential strategy for investigating the dynamic prop- 
erties of MAPs is to examine their behavior in relation to 
other cytoskeleton-associated proteins as they are translo- 
cated along axons after synthesis. The major proteins of the 
axonal cytoskeleton are translocated as constituents of the 
two slowest moving phases of axoplasmic transport, desig- 
nated Group IV or slow component b (SCb), and Group V 
or slow component a (SCa) (Hoffman and Lasek, 1975; Wil- 
lard and Hulebak, 1977; Grafstein and Forman, 1980). Group 
IV, which advances at a rate of 2-20 mm/d, is composed of 
>100 different proteins, including actin, fodrin, myosin-like 
protein, clathrin, and many metabolic enzymes (Black and 
Lasek,  1979;  Willard et al.,  1979;  Willard,  1977; Garner 
and  Lasek,  1981; Brady  and  Lasek,  1981). By  contrast, 
Group V, which advances at a rate of 0.1-1.0 mm/d, is pre- 
dominantly composed of neurofilament proteins and tubulin, 
as well as smaller amounts of fodrin and actin (Hoffman and 
Lasek, 1975; Black and Lasek, 1980).  Although neurofila- 
ment proteins are transported principally as polymers (Nixon 
and Lewis, 1986; Hoffman and Lasek, 1975), tubulin trans- 
port is more complex (see reviews, Hollenbeck, 1989; Nixon, 
1990).  Growing evidence indicates that some tubulin moves 
as soluble dimers (Letourneau and Ressler, 1984; Okabe and 
Hirokawa,  1988;  Tashiro and Komiya,  1989;  Lim et al., 
1989; Bamburg et al., 1986) which then insert into the distal 
(+) ends of preexisting microtubules (Bamburg et al., 1986; 
Okabe and Hirokawa,  1988).  Another fraction of tubulin 
may move in association with insoluble structures represent- 
ing either assembled microtubules (Black et al., 1986; Tash- 
iro and Komiya, 1989) or aggregates of unassembled sub- 
units or protomers (Hollenbeck and Bray, 1987; Weisenberg 
et al.,  1988). 
Several subtypes of tau protein are transported at a Group 
V rate (Tytell et al.,  1984),  which has suggested that these 
polypeptides are attached to microtubules undergoing trans- 
port. The possibility has not been excluded, however, that tau 
protein is transported in association with an unassembled in- 
soluble structure containing Group V components (Weisen- 
berg et al., 1987; Hollenheck and Bray, 1987) or with neuro- 
filament proteins, which can bind tau in vitro (Miyata et al., 
1986).  Aside from tau proteins, no information is available 
about the axoplasmic transport of other MAPs. 
In this study, we characterized the synthesis, axonal trans- 
port, and subsequent fate of a 340-kD MAP. Using biochem- 
ical,  immunochemical,  and  functional  criteria,  we  have 
identified this polypeptide as MAP 1A and provided the first 
information about its in vivo dynamics. Although MAP 1A 
and  microtubules  appear  to  form  functional associations 
within axons in vivo, we observed that MAP 1A and tubulin 
are transported at different rates. A further observation, that 
some  transported  MAP  1A  incorporates  into  a  slowly- 
turning-over stationary cytoskeleton, together with recent 
evidence for populations of stationary microtubules (Lim et 
al.,  1989;  Okabe and Hirokawa, 1988),  explains how con- 
stituents of two  different transport  groups  might become 
physically associated in vivo.  These  findings support  the 
concept that a major portion of  the axonal cytoskeleton is as- 
sembled within axons. The localization in axons of mecha- 
nisms for assembling the cytoskeleton implies a capability 
for local reorganization of the cytoskeleton in response to 
physiological stimuli and for regional specializations of the 
cytoskeleton along axons and within synapses. 
Materials and Methods 
Isotope Injections 
Radiolabeled amino acids were injected intravitreally into anesthetized male 
and female C57Bl/6J mice, aged 10-14 wk, with a calibrated micropipette 
apparatus (Nixon, 1980). Mice received 0.25 #l of  PBS, pH 7.4, which con- 
rained 25  #Ci of L-[2,3-3H]proline (specific activity 30-50 Ci/mmol) or 
50-100  /~Ci of L-[3~S]methionine  (specific activity  400  Ci/mmol)  pur- 
chased from New England Nuclear (Boston, MA). 
The following additional measures were taken in studies on the kinetics 
of  MAP disappearance to reduce variation in amounts of  radiolabeled amino 
acid incorporated into axonal proteins in different animals. For a single ex- 
periment involving 80-100 mice, identical volumes of labeled precursor so- 
lution  were  injected into  all  animals  within a  single 4-h  period  using 
calibrated micropipettes. Repeated experiments were carded out at the same 
time of day to avoid possible circadian variation in protein synthesis or ax- 
onal transport. To reduce the risk of  leakage from the injection site, the bore 
oftbe micropipette (70 #m) and the site and depth of  the injection were stan- 
dardized. A given animal was not analyzed as part of the series if leakage 
of the solution out of the eye was observed (Nixon and Logvinenko, 1986). 
Tissue Preparations 
Mice were killed by cervical dislocation. After the brain was removed and 
cooled, the optic nerve and optic tract were freed from meninges and the 
optic tract on each side was severed at a point 2.5 mm from the superior 
coUiculus. This dissected length of  optic pathway, referred to as optic axons, 
was 9 mm long and consisted of the optic nerves severed at the sclerai sur- 
face of the eye, the optic chiasm, and a length of the optic tract extending 
to, but not including, terminals in the lateral geniculate nucleus. In experi- 
ments involving the radiolabeling of glial cell proteins in vitro, the optic 
pathway was cut at the midpoint  of  the optic chiasm to obtain an optic nerve 
sample for analysis. In other experiments, the optic pathway  was cut into 
consecutive 1.1-mm segments on a  micrometer slide. All manipulations 
were performed at 4°C. 
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Intact,  unlabeled optic pathways,  freshly  dissected  from  mice,  were  in- 
cubated for 60 rain at 37°C in 0.5 ml of a Hepes medium (25 mM Hepes, 
5 mM KCI,  110 mM NaCI, 50 mM glucose, pH 7.4) containing 75 #Ci of 
[35S]methionine (specific activity 400 Ci/mmol).  The medium  was then 
replaced by  1.0 ml of the same medium without radioisotopic amino acid 
but containing protein synthesis inhibitors (0.5 mM cycloheximide) (Sigma 
Chemical  Co.,  St.  Louis,  MO)  and 0.3  mg/ml chloramphenicol (Sigma 
Chemical Co.). Incubation in this medium was continued at 37°C for an ad- 
ditional 5  min.  This was  repeated once to remove unincorporated radio- 
activity, and the tissue was then frozen at  -70°C  until analyzed (Nixon, 
1982). 
Cytoskeleton and Microtubule Preparations 
Cytoskeletal proteins and Triton X-100-soluble protein fractions were pre- 
pared from optic axons by the method of Chiu and Norton (1982). To mini- 
mize proteolysis, buffers in all experiments contained 50/~g/mi leupeptin, 
0.5 mM  PMSF,  and 2.5  mg/ml aprotinin.  Microtubule fractions of optic 
axons and whole mouse brain were prepared from mouse brain by two cycles 
of in vitro assembly and disassembly in MT buffer (50 mM Pipes, pH 6.6, 
1 mM MgSO4,  1 mM EGTA) by the method of Shelanski et al. (1973). For 
co-assembly experiments, optic nerve homogenates were prepared in MT 
buffer containing 1 mM GTP with added brain microtubules. The mixture 
was centrifuged at 100,000 g  for 30 min at 4°C,  and the supernatant was 
incubated at 37°C for 30 min to allow the microtubules to polymerize. The 
microtubules were then spun at 40,000 g  for 30 min at 30°C. 
The microtubule fraction from segments of at least 10 individual radiola- 
beled optic nerves was prepared using the taxol method (Vallee, 1982). The 
tissue was homogenized in 1.5 vol of MT buffer, including protease inhibi- 
tots, and centrifuged in the cold at 100,000  g  for 30 min. The supernatant 
was made 1 mM GTP and 10 v.M taxol,  incubated at 37°C to polymerize 
the microtubules,  and centrifuged at 40,000 g.  The pellet containing the 
microtubule fraction and the supernatant containing the nonmicrotuhule 
fraction were used for PAGE analysis as described in other sections. 
PAGE 
One-dimensional SDS-PAGE was carried out by the method of Laemmli 
(1970) using 320-mm slab gels containing 5-15% or 3-7% polyacrylamide 
gradients (Nixon et al.,  1986). "lM~o-dimensional polyacrylamide gels con- 
taining SDS were prepared with 8-18% polyacrylamide gradients as previ- 
ously described (Brown et al.,  1981). 
Identification and Quantification of 
Radioactive Proteins 
Proteins labeled with [3H]proline were detected by fluorography (Marotta 
et al.,  1979). Proteins labeled with [3SS]methionine were detected by auto- 
radiography.  In some experiments gels were stained with Coomassie blue 
and the appropriate proteins for analysis were identified on gels by compari- 
son with migration of known proteins in cytoskeleton or microtubule prepa- 
rations. The protein bands were cut out and the radioactivity in gel slices 
(disintegrations per minute) was determined as previously described (Nixon 
et al.,  1986). 
lmmunoprecipitation  of  MAPs 
Antibodies against the different forms of MAP 1 were the generous gifts of 
Dr. George Bloom (University of Texas Southwestern Medical Center) and 
Dr. Lester Binder (University of Alabama at Birmingham). They included 
monoclonal antibodies against MAP IA clone IA-1 (Bloom et al., 1985) and 
clone M1.4  (Brown and Binder,  1989);  and antibodies against MAP  IB 
clone  1B-5 (Bloom et ai.,  1985) and clone MAP  1/2 (Safaei and Fischer, 
1989). In addition, we used a polyclonal antibody produced against a cloned 
fusion protein of MAP  1B (Safaei and Fischer,  1989). 
Immunoprecipitation of MAPs from fractions of radiolabeled optic axons 
was  performed  as  previously  described  (Fischer  et  al.,  1986).  Briefly, 
homogenates of optic axons were diluted with 4 vol of buffer containing 50 
mM Tris-HCi, pH 7.6,  190 mM NaCI, 6 mM EDTA,  1.25% Triton X-100, 
and  protease  inhibitors.  The  mixture  was  first cleared  from  nonspecific 
binding by incubation with 50 ~tl protein A-Sepharose gel (Pharmacia Fine 
Chemicals, Piscataway,  NJ) and centrifugation at 11,000 g  for 1 min. The 
sample was immunoprecipitated by incubation with the appropriate ant.ibod- 
ies for 16 h  at 4°C,  followed by addition of protein A-Sepharose for 2  h 
at room temperature.  When monocional antibodies were  used,  a  protein 
A-Sepharose-antibody complex was first prepared by coupling 100 #l of the 
protein A-Sepharose gel with 50/~1 of rabbit anti-mouse antibodies (Cappel 
Laboratories, Malvern, PA). After an extensive washing with 50 mM Tris- 
HCI, pH 7.6, 150 mM NaCI, 5 mM EDTA, and 0.5% Triton X-100, the im- 
munoprecipitated proteins were eluted by boiling in I00 #l of electrophore- 
sis sample buffer for 3  min. 
Quantitation of Total MAPs 
Total  protein content in tissue samples was determined by the method of 
(Lowry et al.,  1951). The total content of MAP IA at different levels of the 
optic pathway  was  determined  by  measuring the quantitative binding of 
Coomassie blue dye to proteins (Bradford, 1976) using a laser densitometer. 
Readings were made on enlarged Mylar transparency prints made from pho- 
tographs of the relevant regions of Coomassie-stained gels. Protein concen- 
trations on gels were within a range that yielded a signal proportional to the 
protein content. Density readings were corrected for variations in the width 
of gel lanes by measuring the total area of the stained band using a digitizing 
board (Summagraphics Corp.,  Fairfield,  CT)  interfaced with a  Bioquant 
software package. Background equivalent to the density of a region in each 
gel lane that contained no protein band was subtracted to compare scans 
from different gel lanes. Density readings from different gels were normal- 
ized to yield the same total density for each replicate experiment. Scans for 
replicate samples on different gels were then averaged together. Fluorographs 
of two-dimensional gels were digitized in a  1,024  ×  1,024 pixel format and 
analyzed using the Visage 110 image system (BioImage, Ann Arbor, M1) and 
its software package. Spot quantitation was computed from the spot boundary 
pixels and the integrated intensity of all the pixels within those boundaries. 
Immunoblot Analysis 
Proteins  separated by  SDS-PAGE  were electrophoretically transferred to 
nitrocellulose membranes (Schleicher &  Schuell, Keene,  NH)) for 1 h at 
0.5 Amp in a  Polyblot apparatus (American Bionetics, Inc.,  Emeryville, 
CA) as described previously (Fischer et al., 1987). The nitrocellulose paper 
was incubated at room temperature with gentle agitation in 50 mM Tris- 
HCI, pH 7.5,  150 mM NaCI (TBS) containing 5% nonfat dry milk (Carna- 
tion, Los Angeles, CA) to block nonspecific binding. The nitrocellulose was 
then reacted overnight at 4°C  with the primary antibodies diluted in the 
same solution. After a thorough washing for 30 rain with TBS, the nitrocel- 
lulose paper was  incubated with horseradish peroxidase-conjngated anti- 
bodies (Cappel  Laboratories),  for  1 h  at room temperature,  washed,  and 
stained with diaminobenzidine. For quantitative analysis, the secondary an- 
tibody  was  replaced  by  '25I-protein A  and the  nitrocellulose paper  was 
washed, dried, and exposed against film for autoradiography. 
Results 
Identification of  MAP 1A in Retinal Ganglion 
Cell Axons 
The proteins in retinal ganglion cells that compose the slow 
phases of axoplasmic transport,  Group IV (1-2 mm/d) and 
Group V (0.2-0.5 mm/d),  were radiolabeled by intravitreal 
injection  of [35S]methionine  and  analyzed  by  SDS-PAGE. 
By 6 d after injection, proteins in both transport groups are 
well-represented  (Fig.  1).  The  major  constituents  of each 
group have been previously characterized  (Nixon and Log- 
vinenko,  1986;  Brown  et  al.,  1982;  Nixon  et  al.,  1982; 
Nixon,  1986). In this study we identified a 340-kD protein 
that was visible by Coomassie blue staining and partitioned 
exclusively into the Triton-soluble fraction (Fig.  1). A pro- 
tein corresponding in molecular mass to the 340-kD protein 
was heavily radiolabeied in optic axons 3 d after [35S]methi- 
onine injection (Fig.  1). About 95 % of the radioactivity as- 
sociated with this protein partitioned into the Triton-soluble 
fraction.  A protein of similar apparent molecular mass was 
Nixon et al. MAP IA and Tubulin Dynamics  In  Vivo  439 Figure  1.  SDS-PAGE  analysis  of  Coomassie  blue- 
stained optic nerve proteins (CB-stain) and radiolabeled 
polypeptides in optic axons of  mice 6 d after intravitreal 
injection  of [35S]methionine (s~S-met) or 3 d after in- 
travitreal  injection  of 32p-orthophosphate  (s2Pi). Un- 
fractionated  optic axons (TOTAL) are compared with 
Triton-soluble  fractions (S) and Triton-insoluble  frac- 
tions (P). Each fraction is derived from one optic path- 
way  (protein  content:  152  ;,g  total,  91  /~g  Triton- 
soluble,  61 #g Triton-insoluble).  Total protein  content 
was revealed by staining with Coomassie blue, and ra- 
diolabeled  proteins  were detected  by autoradiography. 
The gels contained polyacrylamide gradients  of 3-7 %. 
The Coomassie blue and 3sS-labeled protein  patterns 
are from the same three gel lanes. The 340-kD polypep- 
tide is indicated by an arrow and molecular mass esti- 
mations from appropriate standards  are provided. 
labeled  after  intravitreal  injection  of  32p-orthophosphate 
(Fig.  1). 
To examine the relative expression of this protein in neu- 
rons and glial cells,  we labeled glial proteins by incubating 
optic nerves in vitro with psS]methionine for brief periods 
under  conditions  that  largely  preserved  the  structural  in- 
tegrity  of the  axon  and  surrounding  cells  (Nixon,  1983; 
Nixon,  1986). This group of optic nerves and another group 
pooled from mice 6 d after intravitreal  injection of psS]me- 
thionine  were  each  partitioned  into  Triton-soluble  and 
Figure 2.  Comparison of 340-kD protein  synthesized  in 
optic glia  and  retinal  ganglion cells.  The  SDS-PAGE 
(3-7%  gradient)  profiles  of Triton-soluble  (T-sol) and 
Triton-insoluble  (T-insol)  proteins  from  optic  nerves 
stained with Coomassie blue (C8-STAIN) are compared 
with Triton-soluble  and -insoluble  proteins  from optic 
nerves  in which glial  proteins  (GL)  or axonal  proteins 
(AX) were selectively  radiolabeled  with [35S]methionine 
as described in Materials  and Methods.  Labeled proteins 
were revealed  by autoradiography.  Triton-soluble  frac- 
tions (115 #g protein)  and Triton-insoluble  fractions (77 
/zg protein)  for each lane were derived  from three optic 
nerves. 
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from radiolabeled  optic  axons prepared in the presence  of taxol 
(TAXOL-MT)  compared with  soluble  proteins  that  did  not  co- 
assemble with microtubules (TAXOL-sol). Both fractions were de- 
rived from the same 30,000 g supernatant prepared from two radio- 
labeled optic pathways and were loaded onto gels in their entirety. 
Coomassie blue-stained patterns (CB) are compared with the cor- 
responding  autoradiograrns  of  the  35S-labeled axonal  proteins 
(3sS). Radiolabeled optic axons were obtained from mice 3 d after 
intravitreal injection of [35S]methionine. The positions of the 340- 
kD polypeptide  and tubulin  are indicated on these 5-15%  poly- 
acrylamide gels.  Arrows  indicate  relative  position  of molecular 
mass standards in kilodaltons. (Top to bottom) Myosin, 210;/~-galac- 
tosidase,  130; phosphorylase b, 94; BSA, 68; and ovalbumin, 43. 
Triton-insoluble fractions. These fractions were subjected to 
SDS-PAGE, staining with Coomassie blue, and autoradiog- 
raphy. In comparison to the heavy labeling of a 340-kD pro- 
tein in axons (Fig.  2),  only a  minor radioactive band was 
seen  in  the  same  region  of gel  lanes  containing  Triton- 
soluble,  but  not  Triton-insoluble fractions of radiolabeled 
glial proteins (Fig. 2) indicating the possibility of a low level 
of expression of the 340-kD protein in glial cells. 
The properties of the 340-kD protein were studied further 
by preparing a  microtubule-enriched  fraction by the  taxol 
method from a 30,000  g  supematant fraction of [3sS]methio- 
nine-labeled retinal ganglion cell axonal proteins. The 340- 
kD polypeptide in both radiolabeled and unlabeled form, as 
well as several other lower molecular weight proteins, pref- 
Figure 4. Identification of MAP 1A in optic axons by immunopre- 
cipitation and immunoblotting. Optic axons labeled by intravitreal 
injection of [35S]methionine 7 d before analysis were immunopre- 
cipitated using a panel of anti-MAP I antibodies and then resolved 
by a 4-10% SDS-PAGE. (Lanes c and f) Anti-MAP 1B, clone IB-5 
(Bloom et al., 1984) and clone MAP 1/2 (Safaei and Fischer, 1989), 
respectively. (Lanes d and e) Anti-MAP IA, clone IA-I (Bloom et 
al., 1984) and clone M1.4 (Brown and Binder, 1989), respectively. 
Optic axons and whole mouse brain homogenates (lanes a and b, 
respectively) were immunoblotted using anti-MAP 1A, clone IA-I. 
erentiaUy associated with the fraction containing assembled 
tubulin  (Fig.  3).  Similar  results  were  obtained  when  the 
microtubule-enriched fractions were prepared by co-assem- 
bly with purified brain microtubules (data not shown). These 
results  suggested that the  340-kD  protein may be a  MAP 
1-related polypeptide. 
Since  MAP  1 denotes a  group of immunologically and 
structurally distinct polypeptides (Bloom et al.,  1984),  we 
established the relationship of the 340-kD protein to specific 
forms of MAP  1 by immunoblot and immunoprecipitation 
experiments using previously well-characterized antibodies 
to MAP  1A and MAP  lB.  Proteins in optic axons were la- 
beled  in  vivo  with  [35S]methionine  and  the  homogenates 
were immunoprecipitated with a panel of MAP 1 specific an- 
tibodies (Fig. 4). The 340-kD polypeptide was immunopre- 
cipitated  by two antibodies  that  recognize  MAP1A:  clone 
MAP  1A-1 (Bloom  et  al.,  1984)  and  clone  MAP  M1.4 
(Brown and Binder,  1989) as shown in Fig. 4  (lanes d  and 
e, respectively). By contrast, no proteins were immunopre- 
cipitated with two antibodies against MAP 1B: clone MAP 
1B-5 (Bloom et al.,  1984) and clone MAP  1/2 (Safaei and 
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noblot  experiments  with  an  antibody  against  MAP  1A 
confirmed the identity of the protein and showed that the op- 
tic nerve contained the high molecular weight form of MAP 
1A which is equivalent to MAP 1A from whole mouse brain 
homogenates (Fig. 4, lane a and b). In addition, radiolabeled 
optic axons were immunoprecipitated with a panel of anti- 
MAP 1 antibodies as described in Fig. 4, resolved by a 4-10% 
SDS-PAGE, transferred to a  nitrocellulose membrane and 
immunostained with clone MAP IA-1 (Bloom et al.,  1984). 
The immunoprecipitated MAP IA protein detected by auto- 
radiography of the nitrocellulose blot was identical to that of 
the radiolabeled 340-kD polypeptide and the MAP 1A-im- 
munoreactive band from the soluble fraction of optic axons 
homogenates (data not shown). 
Supporting the identification of the 340-kD polypeptide as 
MAP  1A  and  not  MAP  1B  were  additional  immunoblot 
studies of MAP expression in developing optic nerve that 
showed the levels of MAP 1B immunoreactivity to be rela- 
tively high at early phases of  postnatal development (PS) and 
to decrease to almost undetectable levels in the adult mouse 
(data not shown).  This pattern is consistent with previous 
reports on the changes in the relative levels of MAP 1B, or 
related proteins, in developing brain (Bloom et al.,  1985; 
Calvert and  Anderton,  1985;  Riederer and  Matus,  1985; 
Safaei and Fischer,  1989; Schoenfeld et al.,  1989). 
Axoplasmic Transport of  MAP IA in Relation to 
Tubulin 
Since  the  ability  of  MAP  IA  to  bind  to  microtubules 
(Hirokawa, 1982; Shiomura and Hirokawa, 1987a,b) implies 
a  possible  functional  interrelationship,  we  investigated 
whether or not the rate of axonal transport of MAP 1A was 
the same as that of tubulin subunits in optic axons by analyz- 
ing the change in distribution of these polypeptides along op- 
tic axons at three and  seven days after injecting mice in- 
travitreally with [35S]methionine.  Radiolabeled optic axons 
were  cut  into  nine  consecutive  1.1-mm  segments.  The 
100,000 g  supernatant pool of proteins from each segment 
was  assembled  with  taxol to yield a  fraction enriched in 
microtubules and a  fraction of soluble axonal proteins that 
do not assemble with tubulin. The two fractions for each of 
nine segments at two postinjection timepoints were analyzed 
by SDS-PAGE and autoradiography (Fig. 5). A comparison 
of  the distribution of radiolabeled MAP 1A along optic axons 
at three and seven days after [35S]methionine  injection indi- 
cated translocation of MAP  1A from proximal segments to 
more distal segments of optic axons (Fig. 5). 
The distribution of tubulin subunits at these time points 
differed considerably from the patterns for MAP 1A. At 7 d 
after [35S]methionine  injection, radiolabeled ct- and/3-sub- 
units of tubulin were detected primarily in the proximal 2-3 
mm of the optic pathway (Fig. 5). By contrast, MAP 1A ra- 
dioactivity was highest 6-7 mm downstream from the eye. 
Autoradiograms of  corresponding fractions from this experi- 
ment, which contained the radiolabeled axonal proteins that 
do not assemble with tubulin in the presence of Taxol, dis- 
played no detectable radioactivity at the migration position 
of MAP  1A on SDS gels (data not shown). 
Observations that labeled soluble tubulin was localized ex- 
clusively to the first three nerve segments  in Fig.  5  were 
confirmed and extended in two-dimensional SDS-gel studies 
Figure 5.  Distribution of taxol assembled MAP 1A and tubulin 
along consecutive l.l-mm segments of the optic nerve and optic 
tract obtained 3 or 7 d after intravitreal injection of [3SS]methio- 
nine. For each segment, microtubule-enriched insoluble fractions 
prepared  in the presence of taxol were subjected to SDS-PAGE 
(5-15 % acrylamide gradient), and labeled proteins were visualized 
by autoradiography.  The MAP IA region and corresponding tubulin 
region from the same gel are depicted. The graph depicts axoplas- 
mic transport distribution profiles for MAP IA at 3 (o) and 7 (o) d 
after intravitreal [35S]methionine injection are shown. Each point 
represents the mean + SEM for determinations on three to four sets 
of unfractionated optic pathways, each representing the pooled tis- 
sue from five to nine mice. The position of  the tubulin peak radioac- 
tivity at 3 and 7 d is indicated by the single arrow. The position of 
the peak did not change during this short interval. 
of total (soluble and  insoluble) tubulin  distribution.  Con- 
secutive 1.1-mm segments of unfractionated optic pathways 
were obtained from mice 6 d  after intravitreal injection of 
[3H]proline (Fig. 6). Densitometry of the or- and B-tubulin 
region of the fluorograms depicted in Fig. 6  indicated that 
99%  of the detectable tubulin radioactivity was present in 
segments one to three (69, 23, and 7 %, respectively). La- 
beled 50-60-kD polypeptides that were unrelated to tubulin 
based on previous studies  (Brown et al.,  1982) moved at 
Group IV velocities and accounted for the presence of the 
50-60-kD radioactive bands seen in distal nerve segments in 
Fig.  5. 
To establish the rates of axoplasmic transport of MAP 1A 
and tubulins more precisely, we analyzed the changes in the 
distribution  of these  proteins  in  consecutive  1.1-mm  seg- 
ments of the optic axons at various intervals between 0.5 and 
120  d  after  injection  of  [asS]methionine  or  [3H]proline. 
Since MAP IA appears to be the only radiolabeled protein 
migrating at 340-kD on the gels, it can be identified and ana- 
lyzed unambiguously. At each postinjection timepoint, the 
distributions of radioactivity associated with MAP  1A and 
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Figure  7. Regression analyses of movement  of the transport waves 
of MAP  IA (a) or tubulins (b)  as the function of time after in- 
travitreal injection of [35S]methionine  or [3H]proline. Consecutive 
1.1-mm segments of mouse optic pathways were analyzed by SDS- 
PAGE between  0.5  and  120  d  after isotope  injection.  At  each 
timepoint,  the distributions  of radioactivity associated with MAP 
IA and tubulins were plotted (e.g., Fig. 5) to identify the peaks of 
the moving transport  wave for each protein.  The distance of the 
peak from the eye was regressed against the time after isotope ad- 
ministration.  Each point represents one complete analysis. 
Figure 6.  Two-dimensional SDS-PAGE analysis of total (soluble 
plus  insoluble) radiolabeled  tubulin  in seven consecutive  l.l-mm 
segments of unfractionated optic pathway from mice 6 d after in- 
travitreal  injection of [3H]proline. Radiolabel associated with the 
c~- and/~-tubulins, detected by fluorography, is apparent in the first 
the tubulin subunits were quantitated and plotted to identify 
the peaks of the moving transport wave for each protein. The 
rate at which the wave moved was determined by regressing 
the distance of the wave peak from the eye against the time 
after  isotope  administration  (Fig.  7).  These  regression 
curves indicated  that  MAP  1A  advanced  at a  rate of  1.1- 
mm/d, a typical Group IV transport rate (Grafstein and For- 
man, 1980). By contrast, both tubulin subunits advanced at 
a rate of 0.1-0.2 ram/d, the characteristic rate of the Group 
V transport phase (Grafstein and Forman,  1980).  This rate 
corroborates a previous estimate based upon a two-dimen- 
sional gel analysis of tubulin transport in mouse optic axons 
(Brown et al.,  1982). 
Kinetics of  MAP IA Disappearance  from Axons 
The apparent association of MAP  1A with microtubules in 
vitro (see review, Olmsted,  1986)  and by immunoelectron 
microscopic  analysis  (Hirokawa,  1982;  Shiomura  and 
Hirokawa, 1987a,b) makes it difficult to reconcile the finding 
of different transport rates for tubulin and MAP 1A with a 
model in which each of these pools are continuously moving. 
Therefore,  to examine the possibility that a  portion of the 
transported MAP 1A contributes to a stationary cytoskeleton 
and thus can interact with stationary phase microtubules, we 
investigated the long-term fate of newly synthesized MAP 1A 
as it moved through a 9-mm length of the mouse optic path- 
way extending from the proximal optic nerve to the distal op- 
tic tract. The rate at which proteins enter and exit this axonal 
compartment reflects primarily their axoplasmic transport 
rate (Nixon and Logvinenko, 1986). In addition, if the initial 
specific radioactivity of MAP 1A synthesized in retinal gan- 
glion cells is similar in groups of mice allowed to survive for 
different postinjection intervals, it is also possible to quanti- 
three l.l-mm segments, confirming the distribution of soluble tubu- 
lin on one-dimensional gels seen in Fig. 5. A group of  minor labeled 
50-60 kilodalton Group  IV polypeptides  unrelated  to tubulin  is 
designated by arrows in segments 2 and 6. 
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longer than would be predicted from its axoplasmic transport 
rate, as demonstrated previously for neurofilament proteins 
(Nixon and Logvinenko, 1986). 
In each of two experiments, 80-100 mice were injected in- 
travitreally with [3H]proline and analyzed at 11 different in- 
tervals from 1 to 168 d after injection. Changes in the radio- 
activity associated with MAP 1A in the 9-mm length of optic 
axons were quantitated after SDS-PAGE in each of 8-16 mice 
per timepoint. MAP 1A began to disappear from optic axons 
at 8 d after injection. When plotted as a logarithmic function 
of time, the loss of radiolabeled MAP 1A from optic axons 
between 8 and 168 d was biphasic (Fig. 8). The time of initial 
MAP 1A disappearance, calculated by extrapolating the first 
slope in Fig. 8 to 100%, occurred at 8 d, indicating that the 
leading edge of the MAP IA wave advanced at a rate of 1.1 
mm/d, which is identical to the transport rate calculated in 
Fig. 7 using a different method. The first phase of disappear- 
ance between 8 and 45 d, referred to as phase I, occurred 
with a half-life of 12 d. Radiolabeled MAP 1A remaining in 
axons beyond 45 d (phase II) disappeared at a much slower 
rate (t.~ =  55-60 d). The MAP 1A radioactivity retained in 
axons at 45 d after injection (phase II) was 13% of the peak 
MAP  1A radioactivity present at day 4  when radioactivity 
levels are highest. This represents a minimal estimate, since 
extrapolation of the Phase II values to correct for MAP IA 
that has disappeared between 8 and 45 d gave a value of 27 %. 
The residence time of MAP 1A in phase II, however, was 4.6 
times longer than that of MAP 1A in phase I. Therefore, we 
estimated that under steady-state conditions at least 44 % of 
the transported MAP 1A is associated with phase II (Table I). 
In separate experiments, the distribution of the radiola- 
beled MAP IA that is retained in axons after the main wave 
of  transported MAP 1A has exited was determined by analyz- 
ing consecutive 1.1-mm  segments of optic axons by SDS- 
PAGE and fluorography (Fig. 9). The MAP 1A band on au- 
toradiograms of axonal proteins analyzed at intervals from 
1 to  120  d  after  [3H]proline injection was  distinctly  ob- 
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Figure 8. Relative proportions of newly synthesized MAP 1A enter- 
ing and leaving a 9-mm axonal window. In each of  two experiments, 
80-100 mice were injected intravitreally with 25 #Ci [3H]proline. 
At different intervals after injections, optic pathways were dissected 
from groups of these mice. After SDS-PAGE, the radioactivity as- 
sociatexl with MAP IA was quantitated and expressed as a percent- 
age of the radioactivity present in the tissue sample at day 4 after 
injection. Each point is the mean + SEM (error bars) for 8-18 de- 
terminations. Mean radioactivity in MAP 1A at day 4 was 70,486 
dpm. 
Table L  Estimated Proportion  of MAP 1A Associated 
with the Stationary  Cytoskeleton along  Optic Axons 
Relative 
Total  proportions  Total 
pulse-labeled  Half-life  Relative  in the  MAP IA 
Pool  MAP IA*  in axons$  half-life  steady-state§  in axons 
%  d  % 
Phase I 
(moving)  87  13  1.00  87  56 
Phase II 
(stationary)  13  60  4.62  60  44 
* Calculated from the inflection point of the curve describing the biphasic dis- 
appearance of MAP IA in Fig.  8. 
* Calculated from the slopes of lines describing the two phases of MAP disap- 
pearance in Fig. 8. 
§ Calculated by multiplying the size of the pulse-labeled MAP pool  (column 
2) by the relative half-life of the corresponding pool  (column 3). 
teins that were still significantly radiolabeled. Advance of  the 
radiolabeled MAP 1A distally was evident until day 15 after 
isotope injection (Fig. 9, a-c). Although the absolute level 
of radioactivity associated with MAP 1A decreased from 45 
to 120 days, the relative distribution of this label along optic 
axons remained the same (Fig. 9, d and e, and Fig. 10). This 
distribution paralleled the axonal distribution of the total 
content of MAP IA, determined by densitometric analysis of 
Coomassie-stained gels containing consecutive 1.1-mm seg- 
ments of the optic pathway (Fig.  10). 
Discussion 
AxonaUy Transported 340-kD MAP Is MAP 1A 
The results of this study provide the first evidence for the 
synthesis  and  axoplasmic  transport  of a  high  molecular 
weight MAP in neurons in vivo. The identification of the 
transported polypeptide as MAP 1A is based upon co-migra- 
tion on SDS gels with MAP IA from brain microtubules at 
a characteristic electrophoretic mobility (340 kD); its ability 
to co-assemble with microtubules during cycles of assem- 
bly-disassembly;  and  recognition  by  specific  antibodies 
Figure 9.  SDS-PAGE analysis of the distribution of radiolabeled 
MAP  IA along consecutive 1.1-mm segments of optic pathways 
from  mice  at  different  intervals after  intravitreal  injection  of 
[3H]proline. Radiolabeled proteins were visualized after fluorogra- 
phy and exposure times were varied for optimal comparison. The 
distribution profiles are shown for postinjection intervals of 3, 7, 15, 
45, and 120 d (a-e, respectively). The position of MAP IA is indi- 
cated by arrows. 
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Figure 10. Distribution  of MAP 
1A along mouse optic axons. 
Optic  pathways pooled  from 
six to nine mice cut into eight 
consecutive 1.1-mm segments 
were subjected to one-dimen- 
sional  SDS-PAGE.  Proteins 
on the gels were stained with 
Coomassie blue, and the dye- 
binding capacity of the MAP 
IA band, which reflects relative protein content, was determined by 
laser densitometry. Total protein was determined for each segment 
pool, and MAP  1A content in arbitrary units was expressed as a 
fraction of the total protein. Each point (o) is the mean  +  SEM 
(error bars) for six determinations. For comparison, the distribu- 
tions of radiolabeled MAP  IA at 30-45 (zx; n  =  3) or  120 (o; 
n =  1) d after [3H]proline  injection were determined by densitom- 
etry of fluorograms. 
against MAP  1A in immunoblotting and immunoprecipita- 
tion assays. Experiments using a panel of well-characterized 
antibodies (Bloom et al., 1985) further identified the 340-kD 
MAP  as  MAP  1A.  Immunocytochemical studies  indicate 
that MAP 1A forms are present in neurons, including both 
the axonal and dendritic compartments; however, their pres- 
ence  in  glial  cells  and  nonneural  tissues  is  controversial 
(Riederer et al., 1986; Bloom et al., 1984; Herrmann et al., 
1985; Schoenfeld et al.,  1989). In this regard, synthesis of 
MAP 1A in retinal ganglion cells greatly exceeded the level 
of  incorporation of  label into adjacent glial cells under condi- 
tions where proteins common to both cell types, such as fo- 
drin, showed comparable degrees of radiolabeling (Nixon, 
1986). 
Consistent  with  previous  reports  on  the  expression  of 
MAP 1A during development (Bloom et al., 1984; Riederer 
and Matus,  1985; Safaei and Fischer,  1989), levels of the 
340-kD polypeptide in retinal ganglion cells are relatively 
high in the adult.  By contrast, MAP  1B, or the equivalent 
forms of MAP 5 (Riederer et al., 1986), MAP 1 (Calvert and 
Anderton, 1985) and MAP 1.2 (Asai et al., 1985), which are 
present in relatively high levels early in brain development, 
decrease  significantly  in  the  adult  (Bloom  et  al.,  1985; 
Riederer et al.,  1986; Calvert and Anderton,  1985).  Simi- 
larly, MAP 1B was prominent on immunoblots of optic nerve 
proteins of mice at early postnatal ages and decreased to un- 
detectable levels in optic axons of adult mice. 
MAP 1A Is Transported Independently of Tubulin or 
Microtubules along Axons 
MAPs have been shown to associate tightly with microtu- 
bules during assembly experiments in vitro and by immuno- 
cytochemical staining of cells and brain tissue (for review, 
Olmsted, 1986). Immunoelectron microscopy studies of neu- 
ronal cytoskeleton architecture specifically show that MAP 
1A is localized to microtubules (Hirokawa, 1982; Hirokawa 
et al.,  1985; Shiomura and Hirokawa,  1987a,b), suggesting 
a functional interrelationship in vivo. These studies demon- 
strated that MAP 1A extended outward from the microtubule 
wall as thin filaments apparently connecting microtubules to 
each other. It is significant, therefore, that MAP 1A is trans- 
ported along optic axons at a different rate than tubulin. The 
rate of tubulin transport determined in this  study (0.1-0.2 
mm/d) is a typical Group V transport rate and agrees with 
studies in various neuronal systems which show that newly 
synthesized tubulin in CNS axons moves in the slowest phase 
of axoplasmic transport (Brown et al.,  1982; Black and La- 
sek, 1980; Oblinger et al., 1987). In motor and sensory neu- 
rons of peripheral nerves (Mori et al.,  1979; McQuarrie et 
al.,  1986; Tashiro et al.,  1984), a substantial proportion of 
newly synthesized tubulin moves at a Group IV rate. A faster 
moving component of radiolabeled tubulin, however, has not 
been detected in retinal ganglion cells (Brown et al.,  1982; 
Black and Lasek,  1980; Oblinger et al.,  1987). 
Most, if not all, of the newly synthesized MAP 1A in reti- 
nal ganglion cells is transported at a rate of 1.0-1.2 mm/day, 
which is characteristic of the Group IV phase of axoplasmic 
transport in this neuronal system. This rate, determined by 
the conventional method of measuring changes in the ad- 
vance of the moving wave of radiolabeled MAP  1A along 
axons, was confirmed by an independent method (Nixon and 
Logvinenko, 1986) based upon the arrival of MAP IA at a 
distal site along optic axons (i.e., the end of the axonal win- 
dow) and its rate of movement past this site. The constant rate 
of disappearance of radiolabeled MAP 1A from the axonal 
window between 8 and 45 d after injection of radiolabeled 
amino acid implies a single axonal transport rate for most of 
the newly synthesized MAP 1A pool. The axonal transport 
of MAP  1A differs from the behavior of the tau group of 
MAPs which advance along optic axons in the Group V wave 
of axoplasmic transport (Tytell et al.,  1984). Our prelimi- 
nary studies corroborate these findings by identifying several 
polypeptides in the 50-60-kD range that co-assemble with 
microtubules,  selectively immunoprecipitate with anti-tau 
antibodies,  and  advance along  axons at  the characteristic 
Group V rate (Fischer and Nixon, unpublished data). Fur- 
ther studies, however, indicate that, with respect to axonal 
transport,  tau  MAPs  are  atypical  when  compared to  the 
group of radiolabeled proteins in  axons that co-assemble 
with microtubules. The majority of MAPs are synthesized 
and transported along optic axons in Group IV (Fischer, I., 
and R. A. Nixon, unpublished data). 
MAP 1A Contributes to a Stationary Axonal 
Cytoskeleton: Functional Correlates 
If the association between MAP 1A and microtubules shown 
biochemically and viewed ultrastructurally is a physiological 
interaction, the different rates of transport of MAP 1A and 
tubulin imply that some or all of the tubulin and MAP  1A 
must at least transiently move at the same rate or else become 
stationary during their residence within axons. No evidence 
for the former possibility exists; however, our studies indi- 
cate that a  substantial proportion of the newly synthesized 
transported  MAP  1A  deposits  into  a  stationary  network 
along axons. 
Although 85-90% oftbe pulse-radiolabeled MAP 1A con- 
tinuously moved toward axon terminals in Group IV, the re- 
mainder was retained along optic axons for long periods after 
kinetic analyses predicted the  complete elimination  from 
axons of the MAP  1A in Group IV.  Re-use of radiolabeled 
amino  acids  from axonal proteins undergoing proteolysis 
during transport could not account for the retained radiola- 
beled MAP  1A since glial cells synthesized relatively low 
levels of MAP  1A.  Similarly,  synthesis of MAP  1A from 
re-used  pH]proline in  ganglion cell perikarya and  subse- 
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minor to account for the levels of radiolabeled MAP IA re- 
tained in axons at long intervals after intravitreal injection 
(Nixon and Logvinenko, 1986). The retained fraction is also 
unlikely to represent a co-migrating polypeptide unrelated to 
MAP  1A  for several reasons.  Due to its long half-life, it 
would represent more than half of the steady-state level of 
protein at the ~o340 kD position on gels. A polypeptide of 
this abundance would be easily resolved from MAP 1A in 
our studies (Figs.  1, 3, and 4) unless the protein were to be 
previously undescribed  MAP that migrates identically to 
MAP IA on high resolution SDS gels. 
Once the moving wave of radiolabeled MAP 1A reached 
distal ends of optic axons by 12-15 d after injection, the ra- 
diolabeled MAP 1A persisting along axons remained uni- 
formly distributed  at  proximal  and  distal  axonal  levels, 
mimicking the distribution of unlabeled MAP 1A. The con- 
stancy of this distribution pattern over long time intervals af- 
ter isotope injection indicated that this fraction of radiola- 
beled MAP 1A was stationary in axons. The fraction of MAP 
1A retained in axons was at least  13%  of the total pulse- 
radiolabeled MAP 1A, and the residence time of this pool 
of labeled molecules was 4.6 times longer than that of the 
MAP 1A in Group IV. Thus, under steady-state conditions, 
nearly half of the MAP 1A in optic axons is associated with 
stationary axonal structures. These calculations emphasize 
the importance of considering not only the relative radioac- 
tivity of each pool of a particular pulse-labeled protein but 
also the rates of turnover of each when determining the rela- 
tive sizes of the pools in the steady state. 
The existence of a stationary pool of MAP 1A has as a 
precedent the earlier findings that axonally transported neu- 
rofilaments are also incorporated into a stationary neurofila- 
ment network along optic axons (Nixon and Logvinenko, 
1986).  Various  other cytoskeleton-associated proteins also 
contribute  to  the  stationary  axonal  cytoskeleton  (Nixon, 
R. A.,  unpublished observations).  The existence of a  sta- 
tionary population of axonal microtubules, in particular, is 
supported by increasing experimental evidence from other 
laboratories. Tubulin subunits are added at the distal tip of 
the neurite of cultured neurons and primary cultures of dor- 
sal root ganglion ceils (Bamburg et al., 1986; Letourneau and 
Ressler,  1984) consistent with the observation (Heidemann 
et al., 1981) that the sites of subunit addition on microtubules 
(+  end)  are  oriented  exclusively distal  to  the  cell  body 
(Schulze and Kirschner, 1987; Sammak et al., 1987). In neu- 
rites of PC12 cells, biotinylated tubulin dimers microinjected 
into the cell body incorporated mainly at the distal ends of 
neurites.  Immunoelectron microscopy confirmed that free 
tubulin subunits reached distal sites along neurites and be- 
came  locally  incorporated  into  the  neurite  cytoskeleton 
(Okabe  and  Hirokawa,  1988).  Recently,  photobleached 
zones of fluorescently labeled microtubules in PC12  cells 
were shown not to change position along the neurite, indicat- 
ing  that these  microtubules  were  stationary (Lim  et  al., 
1989). Finally, in several neuron systems, a proportion of la- 
beled newly synthesized tubulin persists in proximal regions 
of axons after the moving wave has passed (Watson et al., 
1988;  Nixon, R. A., unpublished data). 
The dynamics of MAP IA transport and deposition rela- 
tive to behavior of tubulin supports the concept that a major 
part of the cytoskeleton assembles locally within axons as in- 
dividual transported cytoskeletal  elements, either in the form 
of subunits or polymers, leave the transport vector (Nixon, 
1987, 1990; Hollenbeck, 1989). The relatively uniform dis- 
tribution of tubulins  (Brown  et  al.,  1982)  and  MAP  IA 
differs from the  increasing proximal-to-distal gradient of 
neurofilaments (Nixon and Logvinenko, 1986) and certain 
other cytoskeletal proteins (Nixon, R. A., unpublished data). 
These  results  accord  with  the  differing stoichiometry of 
microtubules and neurofilaments at  different levels along 
axons (Nixon,  1987) and extend previous evidence for re- 
gional  specialization of the axonal cytoskeleton along its 
length (Brown et al., 1982; Nixon et al., 1982).  The move- 
ment of neurofilament and microtubule proteins in the same 
transport phase has traditionally emphasized the notion of 
the neurofilament-microtubnle lattice as a distinct functional 
unit. Microtubule and neurofilament proteins,  however, move 
independently under a  variety of conditions (for  review, 
Nixon, 1987). Although extensively interconnected in axons, 
neurofilaments and microtubules also appear to be physically 
associated with various axonal polypeptides that move in 
other transport classes (Nixon, 1989). Therefore, it is possi- 
ble that similarity in transport rate overemphasizes the func- 
tional interrelationship between neurofilaments and microtu- 
bules  relative  to  that  between  these  networks  and  other 
cytoskeletal structures. 
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